Analystreport

Ovid Therapeutics Inc (NASDAQ: OVID) had its price target lowered by analysts at Cantor Fitzgerald from $13.00 to $12.00.

Ovid Therapeutics Inc.  (OVID) 
Last ovid therapeutics inc. earnings: 3/11 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.ovidrx.com